HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ichiro Sakuma Selected Research

Body Weight (Weight, Body)

1/2024Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study.
1/2022Association of Low Body Weight with Clinical Outcomes in Elderly Atrial Fibrillation Patients Receiving Apixaban-J-ELD AF Registry Subanalysis.
11/2004Effects of endothelin receptor antagonist on expression of AT1 and AT2 receptors in the heart of SHR-SP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ichiro Sakuma Research Topics

Disease

25Type 2 Diabetes Mellitus (MODY)
04/2024 - 10/2002
20Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 12/2002
18Insulin Resistance
06/2023 - 03/2009
16Coronary Artery Disease (Coronary Atherosclerosis)
08/2023 - 09/2009
13Stroke (Strokes)
01/2022 - 09/2004
13Atherosclerosis
01/2020 - 01/2005
12Hypertriglyceridemia
02/2024 - 06/2004
9Hypercholesterolemia
01/2022 - 04/2010
8Neoplasms (Cancer)
07/2023 - 01/2005
8Atrial Fibrillation
01/2022 - 01/2011
8Hypertension (High Blood Pressure)
07/2017 - 11/2004
7Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2017 - 09/2009
6Obesity
01/2020 - 09/2009
6Ventricular Tachycardia
09/2017 - 01/2007
6Myocardial Ischemia (Ischemic Heart Diseases)
09/2017 - 05/2002
5Mouth Neoplasms (Oral Cancer)
07/2023 - 06/2011
5Myocardial Infarction
11/2022 - 01/2003
5Hemorrhage
01/2022 - 01/2018
5Embolism (Embolus)
01/2022 - 01/2006
5Ischemia
09/2017 - 10/2004
4Shock
12/2023 - 02/2002
4Fibrosis (Cirrhosis)
10/2023 - 11/2003
4Dyslipidemias (Dyslipidemia)
01/2023 - 06/2013
4Ischemic Stroke
11/2022 - 04/2005
4Brain Neoplasms (Brain Tumor)
03/2022 - 01/2008
4Diabetes Mellitus
12/2014 - 11/2004
4Coronary Disease (Coronary Heart Disease)
06/2013 - 10/2002
4Hypoxia (Hypoxemia)
08/2005 - 10/2002
3Body Weight (Weight, Body)
01/2024 - 11/2004
3Heart Failure
12/2023 - 01/2003
3Inflammation (Inflammations)
09/2022 - 06/2004
3Hyperlipidemias (Hyperlipidemia)
03/2011 - 05/2002
2Chronic Renal Insufficiency
02/2024 - 01/2023
2Liver Diseases (Liver Disease)
10/2023 - 11/2019
2Hypovolemia
12/2020 - 07/2013
2Vascular Diseases (Vascular Disease)
01/2018 - 08/2014
2Fetofetal Transfusion (Twin Transfusion Syndrome)
09/2016 - 01/2016

Drug/Important Bio-Agent (IBA)

32Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2023 - 04/2010
20LipidsIBA
01/2024 - 07/2002
17LDL CholesterolIBA
08/2023 - 04/2010
13oxidized low density lipoproteinIBA
08/2023 - 07/2002
10Insulin (Novolin)FDA Link
08/2019 - 10/2002
9pitavastatin (itavastatin)FDA Link
08/2023 - 01/2018
8Glucose (Dextrose)FDA LinkGeneric
06/2023 - 03/2011
8AdiponectinIBA
11/2016 - 09/2009
7CholesterolIBA
07/2017 - 05/2002
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2007 - 10/2002
6(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA
02/2024 - 10/2022
6HDL CholesterolIBA
01/2022 - 06/2004
6Rosuvastatin Calcium (Crestor)FDA Link
11/2016 - 04/2010
6Pravastatin (Pravachol)FDA LinkGeneric
10/2013 - 04/2010
5Sitagliptin Phosphate (Januvia)FDA Link
01/2024 - 01/2020
5Triglycerides (Triacylglycerol)IBA
01/2024 - 02/2012
5Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2023 - 02/2012
5Lipoproteins (Lipoprotein)IBA
03/2016 - 06/2004
5protoporphyrin IXIBA
05/2013 - 01/2006
4AcidsIBA
03/2022 - 01/2008
4AdipokinesIBA
01/2020 - 03/2009
4RivaroxabanIBA
11/2019 - 12/2016
4Fenofibrate (CiL)FDA LinkGeneric
10/2016 - 06/2004
4Endothelin-1 (Endothelin 1)IBA
11/2007 - 11/2004
4Estrogens (Estrogen)FDA Link
07/2004 - 10/2002
3Dipeptidyl-Peptidase IV InhibitorsIBA
04/2024 - 01/2020
3Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2011
3AnticoagulantsIBA
01/2022 - 12/2018
3anagliptinIBA
01/2022 - 01/2020
3LDL Lipoproteins (beta Lipoproteins)IBA
01/2022 - 07/2002
3ProtoporphyrinsIBA
05/2013 - 01/2008
3Oxygen (Dioxygen)IBA
01/2010 - 10/2004
3Proteins (Proteins, Gene)FDA Link
09/2009 - 10/2002
3Endothelins (Endothelin)IBA
11/2007 - 11/2004
2Sodium-Glucose Transport ProteinsIBA
04/2024 - 12/2023
2Hypoglycemic Agents (Hypoglycemics)IBA
04/2024 - 01/2024
21,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA
04/2024 - 09/2023
2Fibric Acids (Fibrates)IBA
02/2024 - 10/2022
2LeptinIBA
01/2024 - 01/2011
2ApolipoproteinsIBA
01/2024 - 01/2023
2CreatinineIBA
12/2023 - 11/2019
2Sodium-Glucose Transporter 2 InhibitorsIBA
12/2023 - 01/2023
2Apolipoprotein B-48IBA
01/2023 - 11/2022
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2022 - 06/2004
2Indicators and Reagents (Reagents)IBA
12/2020 - 01/2010
2Hemoglobins (Hemoglobin)IBA
01/2020 - 10/2004
2Ezetimibe (Zetia)FDA Link
01/2019 - 11/2015
2CalciumIBA
10/2018 - 03/2011
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2016 - 10/2014
2Oxidoreductases (Dehydrogenase)IBA
11/2016 - 08/2014
2Coenzyme A (CoA)IBA
11/2016 - 08/2014
2Simvastatin (Zocor)FDA LinkGeneric
11/2015 - 02/2011

Therapy/Procedure

41Therapeutics
10/2023 - 07/2002
7Catheters
07/2023 - 01/2006
6Lasers (Laser)
12/2023 - 01/2006
4Secondary Prevention
11/2022 - 04/2010
4Light Coagulation
09/2016 - 01/2008
4Hormone Replacement Therapy (Therapy, Hormone Replacement)
03/2005 - 05/2002
3Drug Therapy (Chemotherapy)
09/2022 - 01/2006
3Laser Therapy (Surgery, Laser)
05/2013 - 01/2008
2Chemoradiotherapy
07/2023 - 03/2021
2Electrodes (Electrode)
01/2020 - 01/2011
2Traction
01/2014 - 05/2008